Imaging technologies enhance the value of orthotopic and systemic in vivo models by providing real-time and spatial tracking of disease progression. In this webinar, Dr. Bryan Miller covers the latest advancements in imaging technologies for preclinical in vivo oncology models and discuss how to maximize your studies with the most suitable imaging modalities.
Bryan Miller, PhD, Director, Scientific and Technical Operations, Crown Bioscience
Bryan Miller completed his PhD in Biochemistry at the University of Leicester. He subsequently performed 2 post-doctoral fellowships at the University of Toronto and the Beatson Institute, where he focused on in vivo and in vitro models of colorectal and pancreatic cancer. He has worked in the CRO field since 2015, and joined Crown Bioscience UK in 2019 where he currently serves as Director of Scientific and Technical Operations.
Your privacy is important to us.
We'll never share your information.
© 2025 Crown Bioscience. All Rights Reserved.
© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy
2024-07-03
2024-05-21
landing_page
In Vivo Imaging